Sobi Capital LLC – Trademark Portfolio

Entity Type: 16

Sobi Capital LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ETHOGEN and CRYPTAGION. The owner is based in Cheyenne, WY.

1623 Central Ave, Ste. 18

Cheyenne, WY 82001

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ETHOGEN
ETHOGEN
Registered 2022

Trademark Classifications

Sobi Capital LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Sobi Capital LLC have?

Sobi Capital LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Sobi Capital LLC file in?

Sobi Capital LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Sobi Capital LLC's most well-known trademarks?

Sobi Capital LLC's registered trademark portfolio includes well-known marks such as ETHOGEN and CRYPTAGION. These are among 2 currently registered trademarks in the portfolio.

What is Sobi Capital LLC's trademark registration success rate?

Sobi Capital LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.